Twist Bioscience Corporation Common Stock (TWST) is a publicly traded Healthcare sector company. As of July 16, 2026, TWST trades at $92.74 with a market cap of $5.76B and a P/E ratio of -70.19. TWST moved +0.05% today. Year to date, TWST is +191.96%; over the trailing twelve months it is +154.63%. Its 52-week range spans $23.30 to $105.47. Analyst consensus is strong buy with an average price target of $87.88. Rallies surfaces TWST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TWST, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $92.74 |
| Market Cap | $5.76B |
| P/E Ratio | -70.19 |
| EPS | $-1.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $105.47 |
| 52-Week Low | $23.30 |
| Volume | 1.03M |
| Avg Volume | 0 |
| Revenue (TTM) | $409.48M |
| Net Income | $-81.28M |
| Gross Margin | 52.07% |
9 analysts cover TWST: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $87.88.